Under-recognition of leg dystonia in people with cerebral palsy

Bhooma Aravamuthan1, Toni S Pearson1,2, Keerthana Chintalapati1

  • 1Division of Pediatric Neurology, Department of Neurology, Washington University School of Medicine, St. Louis, MO.

Annals of the Child Neurology Society
|March 11, 2024
PubMed

Insights

Leg dystonia is frequently missed in clinical documentation for individuals with cerebral palsy (CP) and spasticity. Improved documentation and ongoing assessment are crucial for accurate diagnosis and care.

Area of Science:

  • Neurology
  • Pediatrics
  • Movement Disorders

Background:

  • Cerebral palsy (CP) is a common neurodevelopmental disorder.
  • Leg dystonia is a frequent complication of CP-associated spasticity.
  • Accurate documentation of dystonia is essential for effective management.

Purpose of the Study:

  • To determine the rates of clinical under-documentation of leg dystonia in ambulatory individuals with cerebral palsy (CP).

Main Methods:

  • Prospective cohort study of 116 independently ambulatory individuals (age 10-20) with CP-associated spasticity.
  • Gait videos were assessed by movement disorder specialists using the Global Dystonia Rating Scale.
  • Expert assessment was compared against contemporaneous clinic documentation and longitudinal medical records.

Main Results:

  • 70 out of 116 individuals (60%) had leg dystonia identified via gait video analysis.
  • Only 13% of those with dystonia had it documented during their clinic visit.
  • Longitudinal records showed documentation in only 54% of cases.

Conclusions:

  • Leg dystonia is significantly under-documented in individuals with CP and spasticity.
  • Even evaluations by trained clinicians often miss this condition.
  • Vigilance and longitudinal assessment are critical to bridge this diagnostic gap.
Abstract

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
544
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
268
Restless Leg Syndrome and Night Terrors01:27

Restless Leg Syndrome and Night Terrors

Restless Leg Syndrome (RLS), also known as Willis-Ekbom disease, is a neurological disorder characterized by an uncontrollable urge to move the legs due to uncomfortable sensations. These sensations typically occur during periods of rest or inactivity, particularly when lying down or sitting, and can severely disrupt sleep.
The exact cause of RLS is not fully understood, but it is believed to involve dopamine, a neurotransmitter that helps regulate muscle movement. Imbalances in dopamine levels...
177